News Release

Association of monthly high-dose vitamin D supplementation and cancer risk

Peer-Reviewed Publication

JAMA Network

Bottom Line: Monthly high-dose vitamin D supplementation without calcium for up to four years wasn't associated with reduced cancer risk among adults in New Zealand. This study analyzed data from a randomized clinical trial that included a placebo group. There were 328 total cases of  cancer, with 165 among 2,558 participants (6.5 percent) who received monthly high-dose vitamin D supplementation and 163 among 2,550 participants (6.4 percent) in the placebo group. This study suggests monthly high-dose vitamin D supplementation should not be used for cancer prevention.

Authors: Robert Scragg, M.B.B.S., Ph.D., of the University of Auckland, New Zealand, and coauthors


To Learn More: The full study is available on the For The Media website.


Editor's Note: The article contains funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Want to embed a link to this study in your story?: Links will be live at the embargo time

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.